Demecolcine (Colcemid) is used as an antitumor agent that inhibits mitosis by binding to tubulin and preventing spindle formation, thereby arresting cells in metaphase; it is commonly employed in cytogenetics to accumulate metaphase cells for chromosomal analysis; in agriculture, it is utilized to induce polyploidy for breeding new plant varieties; clinically, it is used for the treatment of acute gouty arthritis due to its anti-inflammatory effects and ability to inhibit microtubule polymerization; it has also been reported to exhibit therapeutic efficacy in intervertebral disc herniation by suppressing collagen synthesis and secretion.